These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


425 related items for PubMed ID: 15142145

  • 1. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer.
    Ozdal OL, Aprikian AG, Bégin LR, Behlouli H, Tanguay S.
    BJU Int; 2004 May; 93(7):970-4; discussion 974. PubMed ID: 15142145
    [Abstract] [Full Text] [Related]

  • 2. Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
    Partin AW, Brawer MK, Bartsch G, Horninger W, Taneja SS, Lepor H, Babaian R, Childs SJ, Stamey T, Fritsche HA, Sokoll L, Chan DW, Thiel RP, Cheli CD.
    J Urol; 2003 Nov; 170(5):1787-91. PubMed ID: 14532777
    [Abstract] [Full Text] [Related]

  • 3. [The application of complexed PSA and its relative indexes in the diagnosis of prostate cancer].
    Chen ZH, Zhao J, Wu JM, Xiao CG.
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):36-9. PubMed ID: 12680329
    [Abstract] [Full Text] [Related]

  • 4. Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA.
    Parsons JK, Brawer MK, Cheli CD, Partin AW, Djavan R.
    BJU Int; 2004 Jul; 94(1):47-50. PubMed ID: 15217429
    [Abstract] [Full Text] [Related]

  • 5. Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms.
    Filella X, Truan D, Alcover J, Quintó L, Molina R, Luque P, Coca F, Ballesta AM.
    Urology; 2004 Jun; 63(6):1100-3; discussion 1103-4. PubMed ID: 15183958
    [Abstract] [Full Text] [Related]

  • 6. Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: results of a prospective multicenter study.
    Sözen S, Eskicorapci S, Küpeli B, Irkilata L, Altinel M, Ozer G, Uygur C, Alkibay T, Ozen H.
    Eur Urol; 2005 Mar; 47(3):302-7. PubMed ID: 15716190
    [Abstract] [Full Text] [Related]

  • 7. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
    Stephan C, Stroebel G, Heinau M, Lenz A, Roemer A, Lein M, Schnorr D, Loening SA, Jung K.
    Cancer; 2005 Sep 01; 104(5):993-1003. PubMed ID: 16007682
    [Abstract] [Full Text] [Related]

  • 8. The use of complexed PSA for the early detection of prostate cancer.
    Fischer K, Loertzer H, Fornara P.
    Anticancer Res; 2005 Sep 01; 25(3A):1591-6. PubMed ID: 16033065
    [Abstract] [Full Text] [Related]

  • 9. PSA-related markers in the detection of prostate cancer and high-grade disease in the contemporary era with extended biopsy.
    Bratslavsky G, Fisher HA, Kaufman RP, Voskoboynik D, Nazeer T, Mian BM.
    Urol Oncol; 2008 Sep 01; 26(2):166-70. PubMed ID: 18312936
    [Abstract] [Full Text] [Related]

  • 10. Derivatives of prostate-specific antigen as predictors of incidental prostate cancer.
    Froehner M, Buck LM, Koch R, Hakenberg OW, Wirth MP.
    BJU Int; 2009 Jul 01; 104(1):25-8. PubMed ID: 19191782
    [Abstract] [Full Text] [Related]

  • 11. [Comparative value of molecular forms of prostate-specific antigen in diagnosis of prostatic cancer].
    Mazo EB, Sergeeva NA, Grigor'ev ME, Lebedev DV, Solov'eva EV, Konorev VA, Krovets AA.
    Urologiia; 2006 Jul 01; (3):21-4. PubMed ID: 16889084
    [Abstract] [Full Text] [Related]

  • 12. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.
    Mutlu N, Türkeri LN, Yencilek F, Demir A, Emerk K.
    Can J Urol; 2009 Apr 01; 16(2):4558-67. PubMed ID: 19364428
    [Abstract] [Full Text] [Related]

  • 13. Complexed PSA in routine diagnosis.
    Oremek GM, Sapoutzis N, Eden F, Jonas D.
    Anticancer Res; 2003 Apr 01; 23(2A):975-7. PubMed ID: 12820333
    [Abstract] [Full Text] [Related]

  • 14. Complexed PSA improves prostate cancer detection: results from a multicenter Japanese clinical trial.
    Okihara K, Ukimura O, Nakamura T, Ushijima S, Mizutani Y, Kawauchi A, Naya Y, Kojima M, Miki T.
    Urology; 2006 Feb 01; 67(2):328-32. PubMed ID: 16461082
    [Abstract] [Full Text] [Related]

  • 15. A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis.
    Lein M, Jung K, Hammerer P, Graefen M, Semjonow A, Stieber P, Ossendorf M, Luboldt HJ, Brux B, Stephan C, Schnorr D, Loening SA.
    Prostate; 2001 May 01; 47(2):77-84. PubMed ID: 11340629
    [Abstract] [Full Text] [Related]

  • 16. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M, Jung K, Elgeti U, Brux B, Sinha P, Schnorr D, Loening SA.
    Anticancer Res; 2000 May 01; 20(6D):4997-5001. PubMed ID: 11326657
    [Abstract] [Full Text] [Related]

  • 17. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.
    Okegawa T, Noda H, Nutahara K, Higashihara E.
    Eur Urol; 2000 Oct 01; 38(4):380-7. PubMed ID: 11025374
    [Abstract] [Full Text] [Related]

  • 18. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
    Stephan C, Kramer J, Meyer HA, Kristiansen G, Ziemer S, Deger S, Lein M, Loening SA, Jung K.
    BJU Int; 2007 Jun 01; 99(6):1427-31. PubMed ID: 17355366
    [Abstract] [Full Text] [Related]

  • 19. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME.
    Clin Lab Sci; 2001 Jun 01; 14(2):102-7. PubMed ID: 15625982
    [Abstract] [Full Text] [Related]

  • 20. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
    Tarhan F, Orçun A, Küçükercan I, Camursoy N, Kuyumcuoğlu U.
    Urology; 2005 Dec 01; 66(6):1234-8. PubMed ID: 16360449
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.